<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2013_8_5-6_154</article-id>
<article-id pub-id-type="doi">10.15836/ccar.2013.154</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Jurisic</surname><given-names>Zrinka</given-names></name></contrib><contrib contrib-type="author"><name><surname>Carevic</surname><given-names>Vedran</given-names></name></contrib><contrib contrib-type="author"><name><surname>Martinovic-Kaliterna</surname><given-names>Dusanka</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marasovic-Krstulovic</surname><given-names>Daniela</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bozic</surname><given-names>Ivo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fabijanic</surname><given-names>Damir</given-names></name></contrib>
<aff id="aff1"><institution>University Hospital Center Split</institution>, <addr-line>Split</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Correspondence to Zrinka Jurisic, Klinicki bolnicki centar Split, Spinciceva 1, HR-21000 Split, Croatia; Phone: +385-21-556-111; E-mail: <email xlink:href="zrinkacn@gmail.com">zrinkacn@gmail.com</email></corresp></author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>05</month><year>2013</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>05</month><year>2013</year></pub-date>
<volume>8</volume>
<issue>5-6</issue>
<fpage>154</fpage>
<lpage>154</lpage>
<permissions>
<copyright-statement>Croatian Cardiac Society</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>systemic sclerosis</kwd><kwd>cardiac involvement</kwd><kwd>tissue Doppler echocardiography</kwd><kwd>interleukin-6</kwd></kwd-group>
</article-meta>
</front>
<body>
<p>Background: To assess cardiac involvement in SSc patients and to explore the relationship between interleukin (IL)-6 levels and echocardiographic abnormalities, and NTproBNP levels in SSc patients and to correlate tested parameters with disease activity (EUSTAR) score.</p>
<p>Methods: This case-control study included 31 SSc patients with preserved left ventricular ejection fraction (LVEF) and no concomitant disease, and 32 matched healthy controls. Serum IL-6 and NT-proBNP levels were measured and subjects were evaluated by conventional and pulsed-wave tissue Doppler echocardiography.</p>
<p>Results: SSc patients had significantly lower values of LV systolic (7.7 vs 9.25 cm/s, P&lt;0.001) and early diastolic (8.7 vs 10.3 cm/s, P=0.014) myocardial velocities and higher E/e&#x2019; ratio (9.04 vs 7.37, P=0.001), although there was no between- group difference according to LVEF (68 vs 65%, P=0.248) and E/A ratio (1 vs 1.11, P=0.312). 18 SSc patients had LV systolic dysfunction (septal s&#x2019; &lt;7.5 cm/s) versus 5 control subjects (P=0.010). According to the ASE recommendations, 18 SSc patients and 9 controls had LV diastolic dysfunction (P=0.032). IL-6 level showed correlation with LV mean e&#x2019; (r=-0.57, P=0.001) and E/e&#x2019; ratio (r=0.55, P=0.001). Also, IL-6 level significantly correlated with the presence (r=0.46, P=0.010) and severity (r=0.54, P=0.002) of LVDD and NT-proBNP level (r=0.52, P=0.003) in the SSc group, whereas no correlation was observed in control group. EUSTAR score correlated with LV E/e&#x2019; (r=0.48, P=0.006), mean e&#x2019; (r=-0.67, P&lt;0.001), mean s&#x2019; (r=-0.51, P=0.004), NT-proBNP (r=0.60, P&lt;0.001) and IL-6 (r=0.79, P&lt;0.001), and with LVSD presence (r=0.363, P=0.044), and LVDD presence (r=0.58, P=0.001) and severity (r=0.621, P&lt;0.001). Correlation was also found between IL-6 level and EUSTAR-score (r=0.79, P&lt;0.001)</p>
<p>Conclusions: We showed that subclinical LV impairment is common in patients with SSc who have not already demonstrated cardiac involvement. Positive correlation between IL-6 and EUSTAR score and their association with the echocardiographic abnormalities and NT-proBNP may open up new possibilities for the treatment of SSc cardiomyopathy. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>-<xref ref-type="bibr" rid="r4"><italic>4</italic></xref>)</p>
</body>
<back>
<ref-list>
<title>Literature</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>M</given-names></name><name><surname>Wardell</surname><given-names>J</given-names></name><name><surname>Andersson</surname><given-names>E</given-names></name><name><surname>Samad</surname><given-names>BA</given-names></name><name><surname>Nordlander</surname><given-names>R</given-names></name></person-group>. <article-title>Effects of first myocardial infarction on left ventricular systolic and diastolic function with the use of mitral annular velocity determined by pulsed wave Doppler tissue imaging.</article-title> <source>J Am Soc Echocardiogr</source>. <year>2000</year>;<volume>13</volume>:<fpage>343</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/S0894-7317(00)70003-4</pub-id><pub-id pub-id-type="pmid">10804431</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagueh</surname><given-names>SF</given-names></name><name><surname>Appleton</surname><given-names>CP</given-names></name><name><surname>Gillebert</surname><given-names>TC</given-names></name><etal/></person-group> <article-title>Recommendations for the evaluation of left ventricular diastolic function by echocardiography.</article-title> <source>J Am Soc Echocardiogr</source>. <year>2009</year>;<volume>22</volume>:<fpage>107</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.echo.2008.11.023</pub-id><pub-id pub-id-type="pmid">19187853</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meune</surname><given-names>C</given-names></name><name><surname>Avouac</surname><given-names>J</given-names></name><name><surname>Wahbi</surname><given-names>K</given-names></name><etal/></person-group> <article-title>Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: a controlled study of 100 consecutive patients.</article-title> <source>Arthritis Rheum</source>. <year>2008</year>;<volume>58</volume>:<fpage>1803</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/art.23463</pub-id><pub-id pub-id-type="pmid">18512815</pub-id></mixed-citation></ref>
<ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosello</surname><given-names>S</given-names></name><name><surname>De Santis</surname><given-names>M</given-names></name><name><surname>Lama</surname><given-names>G</given-names></name><name><surname>Spano</surname><given-names>C</given-names></name><name><surname>Angelucci</surname><given-names>C</given-names></name><name><surname>Tolusso</surname><given-names>B</given-names></name></person-group>. <article-title>B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six month follow-up open-label trial.</article-title> <source>Arthritis Res Ther</source>. <year>2010</year>;<volume>12</volume>:<fpage>R54</fpage>. <pub-id pub-id-type="doi">10.1186/ar2965</pub-id><pub-id pub-id-type="pmid">20338043</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
